Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Real-World Effectiveness and Safety of 12 Months of Tralokinumab in Patients with Atopic Dermatitis.
Real-World Effectiveness and Safety of 12 Months of Tralokinumab in Patients with Atopic Dermatitis.
Journal: Dermatology and therapy
Published: May 15, 2026
Emerald Touchless Sensor Quantifies Nighttime Scratching and Sleep Quality in Children With Atopic Dermatitis: PEDISTAD EMERALD Study.
Journal: Dermatology and therapy
Published: April 11, 2026
Summary of Research: Systemic Treatments in Moderate-to-Severe Atopic Dermatitis in Pediatric Patients up to 12 Years of Age: Real-World Treatment Outcomes from the PEDISTAD Registry.
Journal: Dermatology and therapy
Published: October 21, 2025
Pharmacokinetics and Safety of Ustekinumab in Patients with Juvenile Psoriatic Arthritis: Results of the Real-World Ustekinumab Pediatric Opportunistic Pharmacokinetics Study (U-POPS).
Journal: Rheumatology and therapy
Published: September 30, 2025
Systemic Treatments in Moderate-to-Severe Atopic Dermatitis in Pediatric Patients up to 12 Years of Age: Real-World Treatment Outcomes from the PEDISTAD Registry.
Journal: American journal of clinical dermatology
Published: June 17, 2025
Real-world treatment outcomes of systemic treatments for moderate-to-severe atopic dermatitis in children aged less than 12 years: 2-year results from PEDIatric STudy in Atopic Dermatitis.
Journal: Journal of the American Academy of Dermatology
Published: January 31, 2024
Showing 1-6 of 6
Last Updated: 09/26/2026